Effective Aids Treatment and Support in the Free State (FEATS)
FEATS
1 other identifier
interventional
648
1 country
12
Brief Summary
The aim of this study is to investigate the benefits of ARV treatment to patients, to the family members of patients on ARV treatment, and to communities at large. The study also aims to investigate the impact of a peer adherence support and a nutritional intervention on measures of treatment success. To this end, 648 patients who had commenced ARV treatment in the past month at twelve selected health care facilities will be recruited into the study. In addition, 204 randomly sampled households from the communities served by the twelve selected clinics will be recruited into the study. Trained enumerators will at baseline conduct semi-structured interviews with patients and households. Following the baseline survey, patients recruited into the study will be randomly assigned to one of three groups:
- Patients receiving ARV treatment and the associated support currently provided in the public sector ARV treatment programme.
- Patients receiving (a) plus bi-weekly visits by an experienced ARV patient who has been trained as a peer adherence supporter
- Patients receiving (a) and (b) plus a weekly nutritional supplement in the form of two 400g cans of meatballs and spaghetti in tomato sauce The group of 'comparison' households comprises the fourth group. Trained enumerators will conduct follow-up interviews with all patients and households at approximately six- and at twelve-months respectively. In addition, the ARV coordinator and other providers working in the ARV treatment programme at each of the twelve selected health care facilities will be interviewed by trained enumerators, at baseline and again at six- and at twelve-months. Clinical data will be obtained from patient files at baseline and at completion of the study. Using these data, various outcomes of importance to the study will be compared between the four study groups, using experimental and non-experimental methods.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_3
Started Oct 2007
Typical duration for phase_3
12 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedFirst Submitted
Initial submission to the registry
January 12, 2009
CompletedFirst Posted
Study publicly available on registry
January 13, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedFebruary 26, 2009
January 1, 2009
2.2 years
January 12, 2009
February 25, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (9)
CD4 count
6-monthly
RNA viral load
6-monthly
Haemoglobin
6-monthly
self-reported adherence (CASE index)
6-monthly
health-related quality of life (EQ-5D/EQ-VAS)
6-monthly
anthropometrics
monthly to 6-monthly
food security (USDA scales)
6-monthly
time allocation/physical activity levels
6-monthly
household welfare
6-monthly
Secondary Outcomes (5)
mental health (HADS/MHI scales)
6-monthly
labour force participation
6-monthly
employment status
6-monthly
self-reported sexual behaviour
6-monthly
school attendance/performance
6-monthly
Study Arms (4)
1
ACTIVE COMPARATORHouseholds including ARV patients who receive the ARV treatment and associated support provided as part of government's ARV treatment programme - ARV treatment only group
2
ACTIVE COMPARATORHouseholds including ARV patients who receive the ARV treatment and associated support provided as part of government's ARV treatment programme - ARV treatment and ARV peer adherence support group
3
ACTIVE COMPARATORHouseholds including ARV patients who receive the ARV treatment and associated support provided as part of government's ARV treatment programme - ARV treatment, ARV peer adherence support and nutritional support group
4
NO INTERVENTIONRandomly selected households from the general community served by the selected health facility, excluding households where someone is known to receive ARV treatment - comparison/control group
Interventions
Adherence support provided during twice weekly visits to the patient by an experienced ART patients who received basic training in ARV peer adherence support
Weekly delivery by peer adherence supporter (PAS) of two 400g cans of meatballs and spaghetti in tomato sauce
Households including ARV patients who receive the ARV treatment and associated support provided as part of government's ARV treatment programme
Eligibility Criteria
You may qualify if:
- HIV-positive
- Eligible for public sector ARV treatment (CD4\<200 and/or WHO stage 4)
- Commenced ARV treatment in past 4 weeks
- Patient resident in town/village where ART clinic located
You may not qualify if:
- HIV-negative
- Not eligible for public sector ARV treatment
- Had not commenced ARV treatment
- Commenced ARV treatment longer than one month ago
- Patient not resident in town/village where ART clinic
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (12)
Batho clinic
Bloemfontein, Free State, South Africa
MUCPP clinic
Bloemfontein, Free State, South Africa
Tswelepele clinic
Bloemfontein, Free State, South Africa
Refengkhotso clinic
Deneysville, Free State, South Africa
Tshiame clinic
Harrismith, Free State, South Africa
Itumeleng clinic
Jagersfontein, Free State, South Africa
Phomolong clinic
Phomolong, Free State, South Africa
Namahali clinic
Phuthaditjaba, Free State, South Africa
Tseki clinic
Phuthaditjaba, Free State, South Africa
Zamdela clinic
Sasolburg, Free State, South Africa
Matjhabeng clinic
Welkom, Free State, South Africa
Welkom clinic
Welkom, Free State, South Africa
Related Publications (1)
Bhargava A, Booysen FLR, Walsh CM. Health status, food insecurity, and time allocation patterns of patients with AIDS receiving antiretroviral treatment in South Africa. AIDS Care. 2018 Mar;30(3):361-368. doi: 10.1080/09540121.2017.1371665. Epub 2017 Sep 1.
PMID: 28862017DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Frikkie LR Booysen, PhD
University of the Free State
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
January 12, 2009
First Posted
January 13, 2009
Study Start
October 1, 2007
Primary Completion
December 1, 2009
Study Completion
June 1, 2010
Last Updated
February 26, 2009
Record last verified: 2009-01